KYMR

KYMERA THERAPEUTICS INC

KYMR·501575104·US·Common Stock·Healthcare - Biotechnology-Activist

KYMR (KYMERA THERAPEUTICS INC) is held by 135 institutional investors as of Q1 2026. Largest holders: FMR LLC ($974.5M), BAKER BROS. ADVISORS LP ($721.1M), Avoro Capital Advisors LLC ($622.6M). Net institutional sentiment: Mixed.

135
Holders
(11 Elite)
$5.9B
Total Value
57% (138)
Consensus
79 buying - 59 selling
13F: Insider & Congress:
KYMR

Smart Money Verdict

View all
Held by 135 funds
11 elite

Who's Trading

ActivistBVBIOTECHNOLOGY VALUE FUND L P3.3%Jun 26, 2026
InsiderCGChadwick Jeremy GSell $300KMay 27, 2026
InsiderCGChadwick Jeremy GSell $49KMay 27, 2026
InsiderCGChadwick Jeremy GSell $292KMay 26, 2026
InsiderCGChadwick Jeremy GSell $26KMay 26, 2026
InsiderCGChadwick Jeremy GSell $302KMay 26, 2026
InsiderCGChadwick Jeremy GSell $360KMay 26, 2026
InsiderCGChadwick Jeremy GSell $44KMay 26, 2026
ActivistTRT. Rowe Price Investment Management, Inc.6.7%May 15, 2026
ActivistWellington Management Group LLPWellington Management Group LLP4.8%May 15, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.7M(+31.0%)$974.5M0.1%+93.36%
40
Unchanged
8.7M$721.1M4.1%+192.91%
0
Unchanged
7.5M$622.6M6.1%+200.95%
0
Decreased
6.1M(-1.6%)$504.8M0.1%+219.45%
0
Increased
5.1M(+1.1%)$421.5M0.0%+161.92%
31
Decreased
3.9M(-11.9%)$324M0.1%+323.56%
0
New
2.9M$239.9M0.0%+38.22%
43
New
2.9M$239.4M0.0%+38.22%
43
Increased
2.4M(+8.1%)$199M0.0%+174.64%
33
Increased
1.7M(+7.2%)$139.4M0.0%+139.36%
32
Increased
1.6M(+16.1%)$137.1M0.0%+123.08%
35
Decreased
1M(-2.4%)$86.9M0.6%+142.03%
0
Increased
1M(+38.9%)$85.3M0.0%+120.13%
39
Increased
888,409(+20.0%)$74M0.0%+106.62%
35
Decreased
875,872(-4.0%)$73M0.0%+238.18%
0
Increased
836,759(+9.9%)$69.7M0.2%+95.61%
39
Decreased
888,035(-6.7%)$69.1M0.0%+56.26%
0
Increased
759,848(+19.5%)$63.3M0.7%+107.31%
49
Decreased
592,879(-5.0%)$49.4M0.0%+196.08%
0
Decreased
536,680(-29.8%)$44.7M0.1%+87.15%
0

Showing 1-20 of 151

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used